Journal: Current Cancer Therapy Reviews Volume: 17 Issue: 1 Year: 2021 Page: 75-81 Author(s): Amal A. Mohamed,Adel A.-H. Abdel-Rahman,Somia Saad,Shrook Mousa,Omnia Tantawi,Fawkia E. Zahran,Nevine F. Shafik,Reham A.A. Elshimy,Ayman A.-H. Alkhalegy,Alaa Kandil,Rehab Ahmed,Mahmoud Khalil,Moataz Y. Soliman,Yousry E.-E. Abo-Amer,Sherief Abd-Elsalam
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 20 Issue: 6 Year: 2020 Page: 895-902 Author(s): Sawsan I. Khdair,Wassan Jarrar,Yazun Bashir Jarrar,Safaâa Bataineh,Omar Al-Khaldi
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets Volume: 23 Issue: 6 Year: 2023 Page: 850-856 Author(s): Amany A. Ghazy
Journal: Current Pharmacogenomics Volume: 3 Issue: 3 Year: 2005 Page: 191-199 Author(s): Eiji Kawasaki, Katsumi Eguchi
Journal: Letters in Drug Design & Discovery Volume: 14 Issue: 1 Year: 2017 Page: 2-9 Author(s): Ventsislav Yordanov,Ivan Dimitrov,Irini Doytchinova
Journal: Current Pharmaceutical Design Volume: 10 Issue: 2 Year: 2004 Page: 129-143 Author(s): Carl Turesson
Journal: Current Molecular Medicine Volume: 20 Issue: 4 Year: 2020 Page: 275-285 Author(s): Nadin Younes,Salma Younes,Ola. A. Alsharabasi,Mohamed E. El Zowalaty,Ibrahim Mustafa,Mohamed Jahromi,Shahab Uddin,Mariam Al-Nesf,Gianfranco Pintus,Hatem Zayed
Journal: Current Pharmaceutical Design Volume: 15 Issue: 2 Year: 2009 Page: 3262-3273 Author(s): Antonis K. Moustakas, George K. Papadopoulos
Journal: Current Diabetes Reviews Volume: 4 Issue: 2 Year: 2008 Page: 110-121 Author(s): Mourad Aribi
Journal: Current Pharmaceutical Design Volume: 15 Issue: 3 Year: 2009 Page: 4091-4091 Author(s): Bentham Science Publishers
Previous Next